Haoran Guo

Dr. Haoran Guo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
QWQin Wang
Qin Wang
QQQingqing Qin
Qingqing Qin
LWLiang Wenqiang
Liang Wenqiang
HGHaoran Guo
Haoran Guo
YDYang Diao
Yang Diao
XWXin Wang
Xin Wang
During the pathological process of spinal cord injury (SCI), ferroptosis is closely related to mitochondrial homeostasis. Following the occurrence of SCI, the interruption of local blood supply leads to mitochondrial damage within cells and a reduction in Adenosine triphosphate (ATP) production. This results in the loss of transmembrane ion gradients, causing an influx of Ca2+ into the cells, which in turn generates a significant amount of Reactive oxygen species (ROS) and reactive nitrogen species. This leads to severe mitochondrial dysfunction and an imbalance in mitochondrial homeostasis. Ferroptosis is a form of programmed cell death that differs from other types of apoptosis, as it is dependent on the accumulation of iron and lipid peroxides, along with their byproducts. The double bond structures in intracellular polyunsaturated fatty acids (PUFA) are particularly susceptible to attack by ROS, leading to the formation of lipid alkyl free radicals. This accumulation of lipid peroxides within the cells triggers ferroptosis. After SCI, the triggering of ferroptosis is closely associated with the “death triangle”—a core network that catalyzes cell death through the interaction of three factors: local iron overload, collapse of antioxidant defenses, and dysregulation of PUFA metabolism (where PUFA are susceptible to attack by reactive ROS leading to lipid peroxidation). These three elements interact to form a central network driving cell death. In the pathological cascade of SCI, mitochondria serve as both a major source of ROS and a primary target of their attack, playing a crucial role in the initiation and execution of cellular ferroptosis. Mitochondrial homeostasis imbalance is not only a key inducer of the “death triangle” (such as the intensification of lipid peroxidation by mitochondrial ROS), but is also reverse-regulated by the “death triangle” (such as the destruction of mitochondrial structure by lipid peroxidation products). Through the cascade reaction of this triangular network, mitochondrial homeostasis imbalance and the “death triangle” jointly drive the progression of secondary damage. This study aims to synthesize the mechanisms by which various therapeutic approaches mitigate SCI through targeted regulation of mitochondrial homeostasis and inhibition of ferroptosis. Unlike previous research, we integrate the bidirectional regulatory relationship between “mitochondrial homeostasis disruption” and “ferroptosis” in SCI, and emphasize their importance as a synergistic therapeutic target. We not only elaborate in detail how mitochondrial homeostasis—including biogenesis, dynamics, and mitophagy—modulates the initiation and execution of ferroptosis, but also summarize recent strategies that simultaneously target both processes to achieve neuroprotection and functional recovery. Furthermore, this review highlights the translational potential of various treatments in blocking the pathological cascade driven by oxidative stress and lipid peroxidation. These insights provide a novel theoretical framework and propose combinatory therapeutic approaches, thereby laying the groundwork for designing precise and effective comprehensive treatment strategies for SCI in clinical settings.

20 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
SGShijiang Geng
Shijiang Geng
HGHaoran Guo
Haoran Guo
STShengsheng Tian
Shengsheng Tian
QMQizhuo Miao
Qizhuo Miao
YDYang Diao
Yang Diao
XWXin Wang
Xin Wang
Ferroptosis, an iron-dependent regulated cell death driven by lipid peroxidation, contributes to intervertebral disc degeneration (IVDD), yet most reviews describe its pathways without asking why the disc—the largest avascular tissue, combining hypoxia, nutrient deprivation, mechanical loading, acidosis, and low-grade inflammation—regulates ferroptosis differently from other tissues. Here we address this question along three axes. First, the execution machinery shows three IVDD-specific vulnerabilities: a proposed diffusion-limited cystine “semi-starvation”, mechanically induced GPX4 inhibition via the Piezo1–Ca2+ axis, and epigenetic GCLC suppression. Second, iron homeostasis undergoes a “triangular imbalance”: TFR1 upregulation coexists with restricted iron supply, acidosis-activated NCOA4 ferritinophagy is proposed as the dominant source of labile iron (with the UCHL3–HMGB1–NCOA4 axis as a newly identified upstream regulator), and FPN1 export is blocked by the IL-6–hepcidin axis, predisposing Nrf2–HO-1 to a protective-to-deleterious functional reversal. Third, inflammation and ferroptosis form a vicious cycle in which STAT3 signals through the non-canonical S100A6–p53 axis—opposite to its tumour-protective FTH1 role—jointly imposing a “dual lock” on SLC7A11. Integrating these findings, we construct a network in which Nrf2 is proposed as the transcriptional hub and SLC7A11 as the convergent bottleneck, and derive an SLC7A11-restoration hypothesis predicting that multi-target combinations, not single-pathway interventions, will be required—a prediction that remains to be tested. We close by discussing the controversies and a prioritized research agenda.